Healthcare -
Biotechnology - NASDAQ - US
$ 0.906
1.56 %
$ 41.5 M
Market Cap
-0.58
P/E
XLO - TOTAL CURRENT LIABILITIES
Total Current Liabilities XLO - Xilio Therapeutics, Inc.
16 M
LAST VALUE
11.75%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR